A Meta-Analysis of Osteosarcoma Outcomes in the Modern Medical Era

Sarcoma · 2012 · Classic · cited 406 times

Daniel C. Allison, Scott C. Carney, Elke R. Ahlmann, Andrew Hendifar, Sant P. Chawla, А. А. Феденко, et al.

Division of Orthopedic Oncology, Department of Orthopedic Surgery, Keck School of Medicine

Orthopaedic Oncology

SUMMARY — THE REDUCTIONOsteosarcoma survival plateaued since 1980 despite improved limb salvage rates; new systemic strategies needed to advance outcomes for this lethal malignancy.
Abstract, as published

Four decades ago, specialized chemotherapy regimens turned osteosarcoma, once considered a uniformly fatal disease, into a disease in which a majority of patients survive. Though significant survival gains were made from the 1960s to the 1980s, further outcome improvements appear to have plateaued. This study aims to comprehensively review all significant, published data regarding osteosarcoma and outcome in the modern medical era in order to gauge treatment progress. Our results indicate that published survival improved dramatically from 1960s to 1980s and then leveled, or in some measures decreased. Recurrence rates decreased in the 1970s and then leveled. In contrast, published limb salvage rates have increased significantly every recent decade until the present. Though significant gains have been made in the past, no improvement in published osteosarcoma survival has been seen since 1980, highlighting the importance of a new strategy in the systemic management of this still very lethal condition.

Featured in the 2026-06-27 issue.

← Recombinant LGR4 extracellular domain attenuates osteoclastog…Experience with denosumab (XGEVA®) for prevention of skeletal… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.